| Serial Number | 79426106 |
| Word Mark | STAR-CRISPR |
| Filing Date | Tuesday, May 13, 2025 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 17, 2026 |
| Registration Number | 8172915 |
| Registration Date | Tuesday, March 17, 2026 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, January 27, 2026 |
| Goods and Services | Reagents for research purposes; reagents used in science; reagents for scientific purposes; reagents for medical research; laboratory reagents for scientific use; chemical reagents for scientific purposes; reagents for scientific or medical research use; chemical reagents for use in genetic research; chemical reagents for use in biotechnology, other than for medical or veterinary use; specialized reagents for genome editing for scientific, research, and laboratory use; modified cells, in particular genetically modified ips (induced pluripotent stem) cells and differentiated cells derived therefrom, for research or scientific purposes; cell cultures, cell culture systems and cryopreserved genetically modified ips cells for scientific and industrial research purposes; cell cultures, and cryopreserved cells ips cells other than for medical or veterinary use; Biological preparations for use in cell cultures, other than for medical or veterinary purposes, namely, cell culture agents for use in the biotechnology industry and cell material for use in combination with human cells, including genetically modified ips or differentiated stem cells |
| Goods and Services | Medical diagnostic reagents; clinical medical reagents; clinical diagnostic reagents for medical use; reagents for use in medical genetic testing; cells for medical use; genetic identity tests comprised of reagents for medical purposes; specialized reagents for genome editing for medical and medical clinical use; modified cells, in particular genetically modified ips (induced pluripotent stem) cells and differentiated cells derived therefrom, for medical or veterinary use; cell cultures and cell culture systems, and cryopreserved pluripotent stem cells for medical or veterinary use; genetically modified ips (induced pluripotent stem) cells for use in generating other cells for therapeutic purposes; cell cultures and cell culture systems, and cryopreserved genetically modified pluripotent stem cells for sub cultivation of cells, for medical or veterinary use |
| Goods and Services | Custom manufacturing of iPS derived cells, and iPS derived cell therapy and manufacturing processes for others, namely, manufacturing of the foregoing cells in GMP-based facilities; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others, including manufacturing in GMP-based facilities; custom manufacture of cellular therapies, including manufacturing in GMP-based facilities; manufacturing of cell lines being modified cells with specific genetic edits for use in generating other cells |
| Goods and Services | Structural and functional analysis of genomes; research and development in the field of microorganisms and cells; research in the field of gene editing technology; genetic research; gene therapy research; scientific research in the field of genetics and genetic engineering; research in the field of gene therapy; research in the field of genetic diseases; scientific research relating to genetics; biotechnology research; biotechnology testing; preparation of reports in the biotechnology field; research and testing of cell-based products, in particular therapeutic products; research, optimization and testing of cell production processes; laboratory research in the field of biotechnology using genetically modified ips (induced pluripotent stem) cells and differentiated cells derived therefrom; scientific research, design and development of scientific cell culture, cell therapy and gene edited cell therapy; scientific research, design and development of cell culture, cell therapy and gene edited cell therapy, manufacturing systems and manufacturing processes for others; platform as a service (PAAS) services featuring computer software platforms for custom manufacturing of cell-based products in the field of cell therapy, and cell therapy development; providing temporary use of online non-downloadable computer software platform for the management of manufacturing of cell-based therapies, namely, the associated technology, processes, and data analytics capabilities for process optimization and quality control |
| Pseudo Mark | STAR CRISPR |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Celyntra Therapeutics SA |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 98 - Unknown |
| Address | BE |
| Party Name | Celyntra Therapeutics SA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | BE |
| Party Name | Celyntra Therapeutics SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | BE |
| Party Name | Celyntra Therapeutics SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | BE |
| Event Date | Event Description |
| Thursday, June 19, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, June 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, June 22, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, September 3, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, September 16, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 17, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, November 5, 2025 | REFUSAL PROCESSED BY MPU |
| Wednesday, November 5, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 22, 2025 | REFUSAL PROCESSED BY IB |
| Monday, January 5, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 5, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 5, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 6, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 21, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 27, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 27, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 17, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 17, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, June 17, 2026 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, June 25, 2026 | CHANGE OF NAME/ADDRESS REC'D FROM IB |